THE BEST OF ASCO – PORTO ALEGRE – 2016
HCPA, September 10th, 2016
Chair: Prof. G. Schwartsmann
08.00h – 08.150h
Opening
Chairs: G. Schwartsmann & Sergio Azevedo
08.10h – 09.00h
ASCO Plenary Session
Chairs: Sergio Roitman & Jeferson Vinholes
A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Abstract No: LBA1 (Paul E. Goss, MD, PhD) & Discussion (Ian Smith, MD)
Rodrigo Vilarroel (25min)
A Randomized Phase III Study of Temozolomide and Short-Course Radiation vs. Short-Course Radiation Alone in the Treatment of newly diagnosed Glioblastoma in Elderly Patients.
Abstract No: LBA2 (James R. Perry, MD) & Discussion (Stuart A. Grossman, MD)
Bianca Marrone (25min)
09.00h – 09.40h
Oral Presentations/Clinical Science Symposium – Part 1
Chair: Sergio Lago & Fernanda Casarotto
PALOMA-2: Primary Results From a Phase III Trial of Palbociclib Plus Letrozole Compared With Placebo Plus Letrozole in Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (Dennis Slamon)
Pedro Liedke (20min)
Checkmate 032: Nivolumab Alone or in Combination with Ipilimumab for the Treatment of Recurrent Small Cell Lung Cancer (Abstract No: 100; Scott Joseph Antonia , MD, PhD)
Nicolas Lazaretti(20min)
09.40h – 10.20h
Oral Presentations/Clinical Science Symposium – Part 2
Chairs: Roberta Venturella & Lidia Longhinoti
Programmed death-1 blockade in mismatch repair deficient colorectal cancer (Abstract No: 103; Dung T. Le, MD
Henrique Traesel(20min)
Updated results of a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naïve patients with advanced melanoma – CheckMate 067; Jedd D. Wolchok, MD, PhD)
Rodrigo Pereira (20min)
10.20h – 11.50h
CoffeE Break
11.50h – 12.20h
David A. Karnofsky Award Lecture
Chairs: Carla Ismael & Raquel Campana
A lung cancer journey 1975-2016 (Paul A. Bunn, MD, FASCO)
James F. Fleck (30min)
12.20h – 13.30h
Lunch Break
13.30h – 14.00h
Gianni Bonadonna Award Lecture
Chairs: Christian Domenge & Marcelo Warlet Machado
Crosstalk between estrogen and growth fator receptor pathways: Implications for endocrine therapy resistance and new strategies to overcome it” (C. Kent Osborne, MD)
Daniela Rosa (30min)
14.00h – 15.00h
ASCO Highlights 2016 – Part 1
Chairs: Antonio Fabiano F. Filho & Janaina Broilo
Breast Cancer-Triple Negative/Cytotoxics/Local Therapy
Harold J. Burstein , MD, PhD
Fernando Almeida (20min)
Breast Cancer HER2+ and ER+ Disease
Lisa A. Carey , MD
Bruna Castilhos (20min)
Gynecologic Cancer
David R. Spriggs, MD
Alvaro Machado (20min)
15.00h – 15.30h
Coffee Break
15.30h – 16.30h
ASCO Highlights 2016 – Part 2
Chairs: Andrea Moretto & Magnus Rodrigues
Adjuvant, Locally Advanced NSCLC, SCLC, Mesothelioma
Martin J. Edelman , MD
Juliano Coelho (20min)
Lung Cancer-Non-Small Cell Metastatic
Howard Jack West , MD
Guilherme Geib (20min)
Head and Neck Cancer
Robert I. Haddad , MD
Gustavo Biazus (20min)
16.30h -17.50h
ASCO Highlights 2016 – Part 3
Chairs: Jose Roberto Rossari & Sabrina Bedin
Gastrointestinal (Colorectal) Cancer
Richard M. Goldberg , MD
Gabriel Prolla (20min)
Gastrointestinal (Noncolorectal) Cancer
Albert C. Lockhart , MD
Daniela Lessa (20min)
Genitourinary (Prostate) Cancer
Robert Dreicer , MD, MS
Fabio Franke (20min)
Genitourinary (Nonprostate) Cancer
Daniel M. Geynisman , MD
Patricia Moretto (20min)
17.50h – 18.00h
Closing remarks
Chairs: G. Schwartsmann & Sergio Azevedo
